O-015 What can systemic and intracranial proteomic profiles tell us about why some TICI 3 patients do better than others?

In conclusion, intracranial and systemic proteomic differences in TICI 3 subjects may inform why some outcomes are superior to others. Preliminary data presented here provide a springboard for further investigation into how proteins may serve as prognostic biomarkers or therapeutic targets in a subset of MT subjects.Disclosures B. Maglinger: None. J. Frank: None. L. Sheikhi: None. S. Pahwa: None. D. Dornbos: None. C. Rupareliya: None. C. McLouth: None. A. Trout: None. J. Turchan-Cholewo: None. A. Stowe: 4; C; Cerelux, LLC. J. Fraser: 1; C; AHA. 2; C; Penumbra, Medtronic, Stream Biomedical. 4; C; Fawkes Biotechnology; Cerelux, LLC. K. Pennypacker: 4; C; Cerelux, LLC.

Source: Journal of NeuroInterventional Surgery - July 23, 2022 Category: Neurosurgery Authors: Maglinger, B., Frank, J., Sheikhi, L., Pahwa, S., Dornbos, D., Rupareliya, C., McLouth, C., Trout, A., Turchan-Cholewo, J., Stowe, A., Fraser, J., Pennypacker, K. Tags: SNIS 19th annual meeting oral abstracts Source Type: research